Research Article
FOXA1 Expression in Nasopharyngeal Carcinoma: Association with Clinicopathological Characteristics and EMT Markers
Table 3
Multivariate analysis using the Cox proportional hazards model for overall survival (a) and disease-free survival (b).
(a) |
| Covariates | value | HRa | 95% CIb | Lower | Upper |
| FOXA1 expression | 0.051 | 0.214 | 0.046 | 1.004 | pT-stage | 0.645 | 1.211 | 0.536 | 2.736 | Histological type | 0.237 | 0.342 | 0.058 | 2.022 | N-stage | 0.475 | 1.419 | 1.294 | 8.86 | TNM-stage | 0.298 | 2.812 | 0.401 | 19.741 |
|
|
HRa: hazard ratio; 95% CIb: confidence interval.
|
(b) |
| Covariates | value | HRa | 95% CIb | Lower | Upper |
| FOXA1 expression | 0.031 | 0.093 | 0.011 | 0.809 | pT-stage | 0.244 | 0.543 | 0.195 | 1.515 | Histological type | 0.523 | 1.88 | 0.271 | 13.044 | N-stage | 0.05 | 0.072 | 0.005 | 0.996 | TNM-stage | 0.014 | 13.62 | 2.682 | 6.924 |
|
|
HRa: hazard ratio; 95% CIb: confidence interval.
|